<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">chemicallytech</journal-id><journal-title-group><journal-title xml:lang="en">Fine Chemical Technologies</journal-title><trans-title-group xml:lang="ru"><trans-title>Тонкие химические технологии</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2410-6593</issn><issn pub-type="epub">2686-7575</issn><publisher><publisher-name>MIREA – Russian Technological University (RTU MIREA).</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.32362/2410-6593-2019-14-6-95-103</article-id><article-id custom-type="elpub" pub-id-type="custom">chemicallytech-1576</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CHEMISTRY AND TECHNOLOGY OF MEDICINAL COMPOUNDS AND BIOLOGICALLY ACTIVE SUBSTANCES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ХИМИЯ И ТЕХНОЛОГИЯ ЛЕКАРСТВЕННЫХ ПРЕПАРАТОВ И БИОЛОГИЧЕСКИ АКТИВНЫХ СОЕДИНЕНИЙ</subject></subj-group></article-categories><title-group><article-title>Synthesis and properties of Cu- and Pd-complexes of cyclen conjugates with pheophorbide and bacteriopheophorbide</article-title><trans-title-group xml:lang="ru"><trans-title>Синтез и свойства Cu- и Pd-комплексов конъюгатов циклена с феофорбидом и бактериофеофорбидом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7012-8016</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смирнов</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Smirnov</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Смирнов Александр Сергеевич - аспирант кафедры химии и технологии биологически активных соединений, медицинской и органической химии им. Н.А. Преображенского.</p><p>119571, Москва, пр-т Вернадского, д. 86</p></bio><bio xml:lang="en"><p>Alexander S. Smirnov - Postgraduate Student, N.A. Preobrazhensky Department of Chemistry and Technology of Biologically Active Compounds, Medical and Organic Chemistry.</p><p>86, Vernadskogo pr., Moscow 119571</p></bio><email xlink:type="simple">a.smir.on.off@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4333-4516</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Грин</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Grin</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Грин Михаил Александрович - доктор химических наук, профессор, заведующий кафедрой химии и технологии биологически активных соединений, медицинской и органической химии им. Н.А. Преображенского, Scopus Author ID 6603356480.</p><p>119571, Москва, пр-т Вернадского, д. 86</p></bio><bio xml:lang="en"><p>Mikhail A. Grin - Dr. of Sci. (Chemistry), Professor, Head of the N.A. Preobrazhensky Department of Chemistry and Technology of Biologically Active Compounds, Medical and Organic Chemistry, Scopus Author ID 6603356480</p><p>86, Vernadskogo pr., Moscow 119571</p></bio><email xlink:type="simple">michael_grin@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8353-1904</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Миронов</surname><given-names>А. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Mironov</surname><given-names>A. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Миронов Андрей Федорович - доктор химических наук, профессор, кафедра химии и технологии биологически активных соединений, медицинской и органической химии им. Н.А. Преображенского.</p><p>119571, Москва, пр-т Вернадского, д. 86</p></bio><bio xml:lang="en"><p>Andrey F. Mironov - Dr. of Sci. (Chemistry), Professor, N.A. Preobrazhensky Department of Chemistry and Technology of Biologically Active Compounds, Medical and Organic Chemistry, Scopus Author ID 55968884300.</p><p>86, Vernadskogo pr., Moscow 119571</p></bio><email xlink:type="simple">mironov@mitht.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>МИРЭА - Российский технологический университет (Институт тонких химических технологий имени М.В. Ломоносова)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>MIREA - Russian Technological University (M.V. Lomonosov Institute of Fine Chemical Technologies)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>30</day><month>12</month><year>2019</year></pub-date><volume>14</volume><issue>6</issue><fpage>95</fpage><lpage>103</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Smirnov A.S., Grin M.A., Mironov A.F., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Смирнов А.С., Грин М.А., Миронов А.Ф.</copyright-holder><copyright-holder xml:lang="en">Smirnov A.S., Grin M.A., Mironov A.F.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.finechem-mirea.ru/jour/article/view/1576">https://www.finechem-mirea.ru/jour/article/view/1576</self-uri><abstract><sec><title>Objectives</title><p>Objectives. Chlorin and bacteriochlorin photosensitizers are effective agents for cancer photodynamic therapy and fluorescence imaging. They are also excellent chelators forming stable metal complexes. Besides, 64Cu and 109Pd isotopes can serve as emitters for nuclear medicine. Chelation of these metals with cyclen conjugates with chlorin and bacteriochlorin photosensitizers can become a simple and universal strategy for the synthesis of diagnostic and therapeutic radiopharmaceuticals for nuclear medicine. This article reports on the synthesis of similar Cu and Pd complexes of cyclen conjugates with pheophorbide and bacteriopheophorbide and the study of their photophysical properties.</p></sec><sec><title>Methods</title><p>Methods. Metalation of cyclen conjugates was carried out with palladium and copper acetates. For bacteriochlorins, 6-O-palmitoyl-L-ascorbic acid was additionally used as a reducing agent. MALDI mass spectrometry, which was carried out on a time-of-flight mass spectrometer Bruker Ultraflex TPF/TOF and a Bruker Daltonics Autoflex II confirmed the structure of the compounds obtained Electronic absorption spectra were obtained on a Shimadzu 3101 spectrophotometer. Fluorescence and phosphorescence spectra were obtained on a FluoTime 300 PicoQuant spectrofluorometer.</p></sec><sec><title>Results</title><p>Results. Photophysical studies of metal complexes showed that the introduction of palladium cations quenches fluorescence and increases the quantum yield of singlet oxygen generation to 0.98 for the chlorin conjugate. Besides, it decreases the quantum yield of fluorescence to 0.10 and increases the quantum yield of singlet oxygen generation to 0.72 for the bacteriochlorin conjugate. Introducing a copper cation to cyclen conjugates with pheophorbide and bacteriopheophorbide leads to photophysical characteristics quenching.</p></sec><sec><title>Conclusions</title><p>Conclusions. Due to the stability of the synthesized metal complexes in acidic media, as well as the short metalation time (5, 20, 10, and 15 minutes) it is reasonable to expect the successful development of effective imaging agents for positron emission tomography and radionuclide therapy. In addition, the residual fluorescence of bacteriochlorins makes it possible to use fluorescence diagnostics in combination with these methods.</p></sec></abstract><trans-abstract xml:lang="ru"><sec><title>Цели</title><p>Цели. Фотосенсибилизаторы на основе хлоринов и бактериохлоринов являются эффективными агентами для фотодинамической терапии и флуоресцентной визуализации рака. Кроме того, они представляют собой отличные хелаторы, образующие стабильные металлокомплексы, а изотопы 64Cu и 109Pd могут служить в качестве излучателей для ядерной медицины. Хелатирование таких металлов с конъюгатами циклена с хлориновыми и бактериохлориновыми фотосенсибилизаторами может стать простой и универсальной стратегией синтеза диагностических и терапевтических радиофарма-цевтических препаратов для ядерной медицины. В настоящем исследовании сообщается о синтезе подобных Cu- и Pd-комплексов конъюгатов циклена с феофорбидом и бактериофеофорбидом и исследовании их фотофизических свойств.</p></sec><sec><title>Методы</title><p>Методы. Металлирование конъюгатов циклена проводилось ацетатами палладия и меди, для бактериохлоринов дополнительно использовали 6-О-пальмитоил-L-аскорбиновой кислоты в качестве восстановителя. Структуру полученных соединений подтверждали с помощью MALDI-масс-спектрометрии, которую проводили на время-пролетном масс-спектрометре Bruker Ultraflex TPF/TOF и Bruker Daltonics Autoflex II. Электронные спектры поглощения регистрировали на спектрофотометре Shimadzu 3101. Спектры флуоресценции и фосфоресценции были получены на спектрофлуориметре FluoTime 300 PicoQuant.</p></sec><sec><title>Результаты</title><p>Результаты. Фотофизические исследования металлокомплексов показали, что введение катионов палладия приводит к тушению флуоресценции и увеличению квантового выхода синглетного кислорода до 0.98 для хлоринового конъюгата, а также уменьшению квантового выхода флуоресценции до 0.10 и увеличению квантового выхода синглетного кислорода до 0.72 для бактериохлориного конъюгата. Введение катиона меди к конъюгатам циклена с феофорбидом и бактериофеофорбидом приводит к тушению фотофизических характеристик.</p></sec><sec><title>Заключение</title><p>Заключение. Устойчивость синтезированнъх металлокомплексов в кислых средах, а также небольшое время металлирования (5, 20, 10 и 15 мин соответственно) позволяет ожидать успешное создание эффективных визуализирующих агентов для позитронно-эмиссионной томографии и радионуклидной терапии, а остаточная флуоресценция бактериохлоринов делает возможным применение флуоресцентной диагностики в комбинации с данными методами.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>металлокомплексы</kwd><kwd>бактериохлорины</kwd><kwd>хлорины</kwd><kwd>тераностика</kwd><kwd>циклен</kwd><kwd>палладий</kwd><kwd>медь</kwd><kwd>ФДТ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>metal complexes</kwd><kwd>bacteriochlorins</kwd><kwd>chlorins</kwd><kwd>theranostics</kwd><kwd>cyclen</kwd><kwd>palladium</kwd><kwd>copper</kwd><kwd>photodynamic therapy</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена при поддержке гранта РФФИ № 18-03-00961</funding-statement><funding-statement xml:lang="en">This work was supported by the Russian Foundation for Basic Research grant No. 18-03-00961</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Desbois N., Michelin C., Chang Y, Stupar V., Bonnaud M., Pacquelet S., Gros C.P. Synthetic strategy for preparation of a folate corrole DOTA heterobimetallic Cu-Gd complex as a potential bimodal contrast agent in medical imaging. Tetrahedron Lett. 2015;56(51):7128-7131. http://dx.doi.org/10.1016/j.tetlet.2015.11.032</mixed-citation><mixed-citation xml:lang="en">Desbois N., Michelin C., Chang Y, Stupar V., Bonnaud M., Pacquelet S., Gros C.P. Synthetic strategy for preparation of a folate corrole DOTA heterobimetallic Cu-Gd complex as a potential bimodal contrast agent in medical imaging. Tetrahedron Lett. 2015;56(51):7128-7131. http://dx.doi.org/10.1016/j.tetlet.2015.11.032</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Vologdin N., Rolla G.A., Botta M., Tei L. Orthogonal synthesis of a heterodimeric ligand for the development of the Gdlll-Galll ditopic complex as a potential pH-sensitive MRI/ PET probe. Org. Biomol. Chem. 2013;11:1683-1690. http://dx.doi.org/10.1039/C2OB27200H</mixed-citation><mixed-citation xml:lang="en">Vologdin N., Rolla G.A., Botta M., Tei L. Orthogonal synthesis of a heterodimeric ligand for the development of the Gdlll-Galll ditopic complex as a potential pH-sensitive MRI/ PET probe. Org. Biomol. Chem. 2013;11:1683-1690. http://dx.doi.org/10.1039/C2OB27200H</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ranyuk E., Lebel R., Berube-Lauziere Y, Klarskov K., Lecomte R., van Lier J.E., Guerin B. &lt;sup&gt;68&lt;/sup&gt;Ga/DOTA- and &lt;sup&gt;64&lt;/sup&gt;Cu/NOTA-phthalocyanine conjugates as fluorescent/PET bimodal imaging probes. Bioconjug. Chem. 2013;24:1624-1633. https://doi.org/10.1021/bc400257u</mixed-citation><mixed-citation xml:lang="en">Ranyuk E., Lebel R., Berube-Lauziere Y, Klarskov K., Lecomte R., van Lier J.E., Guerin B. &lt;sup&gt;68&lt;/sup&gt;Ga/DOTA- and &lt;sup&gt;64&lt;/sup&gt;Cu/NOTA-phthalocyanine conjugates as fluorescent/PET bimodal imaging probes. Bioconjug. Chem. 2013;24:1624-1633. https://doi.org/10.1021/bc400257u</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Park J.-A., Kim J.Y, Lee Y.J., Lee W., Lim S.M., Kim T.-J., Yoo J., Chang Y., Kim K.M. Gadolinium complex of 125I/127I-RGD-DOTA conjugate as a tumor-targeting SPECT/MR bimodal imaging probe. ACS Med. Chem. Lett. 2013;4:216-219. https://doi.org/10.1021/ml3003499</mixed-citation><mixed-citation xml:lang="en">Park J.-A., Kim J.Y, Lee Y.J., Lee W., Lim S.M., Kim T.-J., Yoo J., Chang Y., Kim K.M. Gadolinium complex of 125I/127I-RGD-DOTA conjugate as a tumor-targeting SPECT/MR bimodal imaging probe. ACS Med. Chem. Lett. 2013;4:216-219. https://doi.org/10.1021/ml3003499</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Waghorn P.A., Labrl J., Radiolabelled porphyrins in nuclear medicine. Compd. Radiopharm. 2014;57:304-309. https://doi.org/10.1002/jlcr.3166</mixed-citation><mixed-citation xml:lang="en">Waghorn P.A., Labrl J., Radiolabelled porphyrins in nuclear medicine. Compd. Radiopharm. 2014;57:304-309. https://doi.org/10.1002/jlcr.3166</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ke T., Feng Y, Guo J., Parker D.L., Lu Z.R. Biodegradable cystamine spacer facilitates the clearance of Gd(III) chelates in poly(glutamic acid) Gd-DO3A conjugates for contrast-enhanced MR imaging. Magn. Reson. Imaging. 2006;24:931-940. https://doi.org/10.1016/j.mri.2006.03.009</mixed-citation><mixed-citation xml:lang="en">Ke T., Feng Y, Guo J., Parker D.L., Lu Z.R. Biodegradable cystamine spacer facilitates the clearance of Gd(III) chelates in poly(glutamic acid) Gd-DO3A conjugates for contrast-enhanced MR imaging. Magn. Reson. Imaging. 2006;24:931-940. https://doi.org/10.1016/j.mri.2006.03.009</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Smith S.V. Molecular imaging with copper-64. J. Inorg. Biochem. 2004;98:1874-1901. http://dx.doi.org/10.1016/j.jinorgbio.2004.06.009</mixed-citation><mixed-citation xml:lang="en">Smith S.V. Molecular imaging with copper-64. J. Inorg. Biochem. 2004;98:1874-1901. http://dx.doi.org/10.1016/j.jinorgbio.2004.06.009</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Shi J., Tracy W.B. Liu, Chen J., Green D., Jaffray D., Wilson B.C., Wang F., Zheng G. Transforming a targeted porphyrin theranostic agent into a PET imaging probe for cancer. Theranostics. 2011;1:363-370. http://dx.doi.org/10.7150/thno/v01p0363</mixed-citation><mixed-citation xml:lang="en">Shi J., Tracy W.B. Liu, Chen J., Green D., Jaffray D., Wilson B.C., Wang F., Zheng G. Transforming a targeted porphyrin theranostic agent into a PET imaging probe for cancer. Theranostics. 2011;1:363-370. http://dx.doi.org/10.7150/thno/v01p0363</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">De Leon-Rodriguez L.M., Kovacs Z. The synthesis and chelation chemistry of DOTA-peptide conjugates. Bioconjug. Chem. 2008;19:391-402. http://dx.doi.org/10.1021/bc700328s</mixed-citation><mixed-citation xml:lang="en">De Leon-Rodriguez L.M., Kovacs Z. The synthesis and chelation chemistry of DOTA-peptide conjugates. Bioconjug. Chem. 2008;19:391-402. http://dx.doi.org/10.1021/bc700328s</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Chong H.S., Mhaske S., Lin M., Bhuniya S., Song H.A., Brechbiel M.W., Sun X. Novel synthetic ligands for targeted PET imaging and radiotherapy of copper. Bioinorg. Med. Chem. Lett. 2007;17:6107-6110. http://dx.doi.org/10.1016/j.bmcl.2007.09.052</mixed-citation><mixed-citation xml:lang="en">Chong H.S., Mhaske S., Lin M., Bhuniya S., Song H.A., Brechbiel M.W., Sun X. Novel synthetic ligands for targeted PET imaging and radiotherapy of copper. Bioinorg. Med. Chem. Lett. 2007;17:6107-6110. http://dx.doi.org/10.1016/j.bmcl.2007.09.052</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Sprague J.E., Peng Y., Fiamengo A.L, Woodin K.S., Southwick E.A., Weisman G.R., Synthesis, characterization and in vivo studies of Cu(II)-64-labeled cross-bridged tetraazamacrocycle-amide complexes as models of peptide conjugate imaging agents. J. Med. Chem. 2007;50:2527-2535. http://dx.doi.org/10.1021/jm070204r</mixed-citation><mixed-citation xml:lang="en">Sprague J.E., Peng Y., Fiamengo A.L, Woodin K.S., Southwick E.A., Weisman G.R., Synthesis, characterization and in vivo studies of Cu(II)-64-labeled cross-bridged tetraazamacrocycle-amide complexes as models of peptide conjugate imaging agents. J. Med. Chem. 2007;50:2527-2535. http://dx.doi.org/10.1021/jm070204r</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Dilworth J.R., Pascu S.I., Waghorn P.A., Vullo D., Bayly S.R., Christlieb M., Sun X., Supuranc C.T. Synthesis of sulfonamide conjugates of Cu(II), Ga(III), In(III), Re(V) and Zn(II) complexes: Carbonic anhydrase inhibition studies and cellular imaging investigations. Dalton Trans. 2015;44:4859-4873. http://dx.doi.org/10.1039/C4DT03206C</mixed-citation><mixed-citation xml:lang="en">Dilworth J.R., Pascu S.I., Waghorn P.A., Vullo D., Bayly S.R., Christlieb M., Sun X., Supuranc C.T. Synthesis of sulfonamide conjugates of Cu(II), Ga(III), In(III), Re(V) and Zn(II) complexes: Carbonic anhydrase inhibition studies and cellular imaging investigations. Dalton Trans. 2015;44:4859-4873. http://dx.doi.org/10.1039/C4DT03206C</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Mironov A.F. Lanthanide porphyrin complexes. Russ. Chem. Rev. 2013;82:333-351. https://doi.org/10.1070/RC2013v082n04ABEH004300</mixed-citation><mixed-citation xml:lang="en">Mironov A.F. Lanthanide porphyrin complexes. Russ. Chem. Rev. 2013;82:333-351. https://doi.org/10.1070/RC2013v082n04ABEH004300</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Josefsen L.B., Boyl R.W. Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics. Theranostics. 2012;2:916-966. http://dx.doi.org/10.7150/thno.4571</mixed-citation><mixed-citation xml:lang="en">Josefsen L.B., Boyl R.W. Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics. Theranostics. 2012;2:916-966. http://dx.doi.org/10.7150/thno.4571</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Das T., Chakraborty S., Sarma H.D., Banerjee S., Venakatesh M. A novel 177Lu-labeled porphyrin for possible use in targeted tumor therapy. Nucl. Med. Biol. 2010;37:655-663. http://dx.doi.org/10.1016/j.nucmedbio.2010.02.007</mixed-citation><mixed-citation xml:lang="en">Das T., Chakraborty S., Sarma H.D., Banerjee S., Venakatesh M. A novel 177Lu-labeled porphyrin for possible use in targeted tumor therapy. Nucl. Med. Biol. 2010;37:655-663. http://dx.doi.org/10.1016/j.nucmedbio.2010.02.007</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kilian K., Pyrzynska K. The fast method of Cu-porphyrin complex synthesis for potential use in positron emission tomography imaging. Talanta. 2003;60:669-678. http://dx.doi.org/10.1016/j.saa.2016.01.045</mixed-citation><mixed-citation xml:lang="en">Kilian K., Pyrzynska K. The fast method of Cu-porphyrin complex synthesis for potential use in positron emission tomography imaging. Talanta. 2003;60:669-678. http://dx.doi.org/10.1016/j.saa.2016.01.045</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Grin M.A., Brusov S.S., Shchepelina E.Y, Ponomarev P.V., Khrenova M.K., Smirnov A.S., Lebedeva V.S., Mironov A.F. Calixresorcinarene-capped silver nanoparticles as new supramolecular hybrid nanocontainers. Mendeleev Commun. 2017;27:338-340. http://dx.doi.org/10.1016/j.mencom.2017.07.004</mixed-citation><mixed-citation xml:lang="en">Grin M.A., Brusov S.S., Shchepelina E.Y, Ponomarev P.V., Khrenova M.K., Smirnov A.S., Lebedeva V.S., Mironov A.F. Calixresorcinarene-capped silver nanoparticles as new supramolecular hybrid nanocontainers. Mendeleev Commun. 2017;27:338-340. http://dx.doi.org/10.1016/j.mencom.2017.07.004</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Q., Huang Z., Luck D., Beckers J., Brun P.H., Wilson B.C., Scherz A., Salomon Y., Hetzel F.W. Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancer. Photochem Photobiol. 2002;76:438-445. http://dx.doi.org/10.1562/0031-8655(2002)076&lt;0438:PSINCP&gt;2.0.CO;2</mixed-citation><mixed-citation xml:lang="en">Chen Q., Huang Z., Luck D., Beckers J., Brun P.H., Wilson B.C., Scherz A., Salomon Y., Hetzel F.W. Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancer. Photochem Photobiol. 2002;76:438-445. http://dx.doi.org/10.1562/0031-8655(2002)076&lt;0438:PSINCP&gt;2.0.CO;2</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
